You have been chosen to receive this valuable information. Let us show you why the TRS100 is the ideal choice for quality-control testing in your pharma lab. For content uniformity, assay, and ID tests, the TRS100 reduces runtime to minutes per batch. Let us show you why the TRS100 is the ideal choice for quality-control testing in your pharma lab The Agilent TRS100 Raman system enables rapid pharmaceutical quality-control testing, including whole tablet or capsule assays as well as polymorph analysis. For content uniformity, assay, and ID tests, the TRS100 reduces runtime to minutes per batch, saving significant cost and speeding up your QC workflow. • Proven for content uniformity, assay, and ID for solid formulations • Low cost per test and no consumables • Fast tests and no sample prep — ideal for high volume testing • Quantify APIs and polymorphs in a single measurement Try the TRS100 with your samples Our transmission Raman application specialists will work with you to evaluate how the TRS100 can benefit your QC and R&D workflows. Contact us Watch our user presentations to learn how pharmaceutical companies are using their TRS100 systems, or get in touch to try TRS technology with your samples. Watch on-demand presentations from pharmaceutical users of the TRS100, including: Implementing Transmission Raman for Fast Content Uniformity Testing — from Feasibility Evaluation to a Validated Release Method Watch webinar Meike Römer, Ph.D. Process Analytical Technology Manager, Grünenthal Pharma, Germany Agilent Home About Agilent Legal Subscriptions 5301 Stevens Creek Blvd, Santa Clara CA 95051, USA Agilent is committed to respecting and protecting your privacy. To view the promises that we make to you regarding your personal information, please view Agilent's privacy statement . For questions related to privacy, please send your inquiry to . If you prefer not to receive promotional e-mails from Agilent in the future, you can unsubscribe at any time. You can also update your e-mail address, contact information, or interest profile to ensure you receive the most relevant information. ©Agilent Technologies, Inc. 2019 View this email in web or text Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology and LCGC Europe, a UBM publication. You are on the mailing list as %%emailaddress%%.